A case for the use of low-molecular-weight-heparin: the pharmacoeconomics of LMWHs-making the case

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalPharmacy & Therapeutics
Volume26
StatePublished - Jan 1 2001

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this